FDAFDA · Food and drugs·Recall number D-0432-2023
Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4
Published March 8, 2023 · Recall initiated: February 23, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Packaging defect: observed packaging defect, blister packaging inadequately sealed.
What to do
Voluntary: Firm initiated
Recall details
- Manufacturer
- The Harvard Drug Group
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot: M04145 Exp. 01/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.